Member Info for formerlyeasyp

Timescale?

Stop lossed some time ago but remain interested in CTL. On the plus side the company has institutional investors. The negatives imo are the current cash position and timescale to achieve permits to start mining. I did my research via FT.com portfolio.

Is EEE sat on any copper? Over the past year we have quite rightly focused on Titanium but in one of the early RNS it mentions copper. Copper resources likely to attract bidders over the next few years.

Interesting thank you!

Does the tech owned and sold by POS count as "enabling technology"? Doomberg is not a fan of oil & gas producers but does see enabling tech as a good source of profit.

Excellent grades and just below the surface!

800 shares....globally or just in London?

Check out how many institutional investors bought into GTE in 2025.

Well the sp has enjoyed a recent run up.

Carney was with Trump 24hrs ago.

Maybe oil & gas back in fashion?

Use the filter option against shorter?

Impressed by the CEO buying up shares.

Impressed that is has institutional investors.

Concerned about debt to capital ratio.

Thoughts please?

Https://www.zerohedge.com/energy/nuclear-key-powering-data-center-boom

Cheap Abundant electricity = Nuclear Power

Https://www.zerohedge.com/energy/nuclear-key-powering-data-center-boom

Invest in engineering companies able to build power plants and fuel producing miners & processors.

Rick Rule points out if you invest in small exploration companies you have to be able to deal with two things. First, your stake could end up 50% down and second, you have to be in early & willing to wait a few years for a good return.

Ignore the noise on this board and read the reports. Consider what is on offer and which other miners are involved? Then set your timescale and consider whether to invest?

Anzá Project - Colombia - Orosur Mining https://share.google/whhVGJbdHLnVSDs5q

I saw the same in ft.com portfolio and ignored it. I am interested because of the grades and the fact that TYM has a modest revenue stream and not much debt. Even so its a punt imo.

"BIO continues to make regular payments as part of the revised advance royalty payment schedule of US$2.4m to be paid in full by the end of 2026, as announced on 18 August 2025."

That helps!

Modest contract but feels to me like a good time to climb back on board.

Unicorn has added to its stake in the company.

"Cash runway extended into 2027, supporting the delivery of multiple key clinical milestones"

Most reassuring! Just a matter of patience imo.

In terms of revenue what is this RNS valued at please?

Https://www.lse.co.uk/ShareShortPositions.html?shareprice=RENX&share=Renalytix-Plc

Early investors will take risks invest and then sell early just as small private investors are getting on board. There is also the problem of shorter.